We are pleased to announce that our long awaited next generation sequencing (NGS) screening service for familial hypercholesterolaemia (FH) has ‘gone live' on Wednesday October 2nd.
All samples received by the AWMGS from 12th August 2019 for FH gene sequencing and copy number analysis will have been processed using the OGT SureSeq Cardiff Custom FH Panel v1.
We are planning on increasing the genomic targets included as part of our routine FH screening service; aiming for this more comprehensive screening service to be available in January 2020.